BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
World J Clin Pediatr. Mar 9, 2026; 15(1): 113430
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.113430
Understanding recurrent wheezing: A parent’s guide
Thamonpan Kiatvitchukul, Pandaree Dokkham, Kornthip Jeephet, Klaita Srisingh
Thamonpan Kiatvitchukul, Pandaree Dokkham, Klaita Srisingh, Department of Pediatrics, Naresuan University, Phitsanulok 65000, Thailand
Kornthip Jeephet, Statistics Technical Officer, Research Center of the Faculty of Medicine, Naresuan University, Phitsanulok 65000, Thailand
Author contributions: Srisingh K and Kiatvitchukul T designed the study; Kiatvitchukul T and Srisingh K were responsible for developing the methodology; Dokkham P, Jeephet K and Srisingh K participated in the formal analysis and investigation; Kiatvitchukul T and Srisingh K wrote the original draft; Srisingh K had full access to all study data and was responsible for the integrity of the data and the accuracy of the analysis; Srisingh K also confirmed that all authors met authorship criteria and was responsible for submitting the manuscript; and all authors have read and approve the final manuscript.
Institutional review board statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. The study was approved by the Naresuan University Institutional Review Board (COA No. 172/2025, IRB No. P3-0055/2568).
Informed consent statement: Since this research was retrospective in nature, individual informed consent was not required. However, in cases where clinical data were incomplete, participants were contacted via telephone to obtain the missing information. Verbal informed consent was obtained from all participants prior to data collection. All necessary ethical considerations, including data confidentiality and adherence to both institutional and international ethical standards, were strictly followed.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Data sharing statement: The data presented in this study are available on request from the corresponding author. The data are not publicly available due to patients’ privacy restrictions.
Corresponding author: Klaita Srisingh, Associate Professor, Department of Pediatrics, Naresuan University, 99 Moo 9, Phitsanulok-Nakhonsawan Road, Thapho Subdistrict, Phitsanulok 65000, Thailand. klaitas@nu.ac.th
Received: August 26, 2025
Revised: November 7, 2025
Accepted: November 27, 2025
Published online: March 9, 2026
Processing time: 193 Days and 4.8 Hours
Abstract
BACKGROUND

Recurrent wheezing following acute lower respiratory tract infection (ALRTI) in early childhood is a common clinical problem and may be an early indicator of chronic respiratory diseases. Early identification of associated risk factors is essential for early intervention and prevention.

AIM

To investigate the risk factors and timing of recurrent wheezing episodes following ALRTI in children.

METHODS

A retrospective cohort study was conducted among pediatric patients ≤ 5 years old admitted with ALRTI and wheezing at Naresuan University Hospital between July 1, 2020 and June 30, 2023. Participants were followed for 12 months. Data from electronic and paper records were analyzed using STATA 18.0. Multivariable logistic regression identified independent risk factors. Kaplan-Meier analysis and log-rank tests compared recurrence and non-recurrence groups through survival curves.

RESULTS

Significant predictors of recurrent wheezing included age 12-24 months [odds ratio (OR): 2.38; 95%CI: 1.50-3.78, P < 0.001], prematurity (OR: 1.66; 95%CI: 1.07-2.58, P = 0.024), allergic rhinitis (OR: 1.50; 95%CI: 1.04-2.17, P = 0.031), urban residency (OR: 1.68; 95%CI: 1.19-2.38, P = 0.003), eosinophilia (absolute eosinophil count > 500 cells/μL) (OR: 3.29; 95%CI: 1.57-6.91, P = 0.002), and prior lower respiratory tract infection (OR: 1.82; 95%CI: 1.20-2.76, P = 0.005). The median time to recurrence was 100 days (interquartile range: 43-125), varying across clinical and environmental subgroups.

CONCLUSION

Children with certain demographic and clinical features have higher recurrent wheezing risk after ALRTI, highlighting the need for closer monitoring and early preventive care.

Keywords: Acute lower respiratory tract infection; Recurrent wheezing; Pediatric asthma; Chronic respiratory diseases; Childhood

Core Tip: This study examined children hospitalized with acute lower respiratory tract infections and wheezing, identifying several independent risk factors for recurrent wheezing, including age 12-24 months, prematurity, allergic rhinitis, urban residence, eosinophilia, and prior lower respiratory tract infection. Notably, the median time to recurrence was 100 days, providing practical insight for optimizing follow-up timing and early intervention strategies.